Robert Barrow

Chief Development Officer

Mr. Barrow is an accomplished pharmaceutical executive and clinical pharmacologist with over a decade of experience leading drug development programs in a variety of disease areas. Mr. Barrow previously served as Director of Drug Development & Discovery at Usona Institute, where he oversaw preclinical, clinical and regulatory development efforts for all of Usona’s development programs. Prior to joining Usona, Mr. Barrow served as Chief Operating Officer of Olatec Therapeutics where he oversaw the execution of numerous early- and late-stage clinical trials in the fields of analgesics, rheumatology, immunology and cardiovascular disease. In addition, he has been responsible for the design and execution of preclinical research programs for new molecular entity drugs in CNS conditions such as multiple sclerosis, Alzheimer’s Disease and Parkinson’s Disease. Mr. Barrow holds a Masters degree in Pharmacology from The Ohio State University and a Bachelor of Science degree from Wake Forest University, where he graduated summa cum laude.

JR Rahn Portrait

JR Rahn

Chief Executive Officer, Board Director, & Co-Founder
Dr. Miri Halperin Wernli Portrait

Dr. Miri Halperin Wernli

Executive President; Board Director; Chair of Technology Evaluation, Acquisition and Scientific Integrity Board Committee
Robert Barrow Portrait

Robert Barrow

Chief Development Officer
Carol Nast Portrait

Carol Nast

Chief Operating Officer
Donald Gehlert, PhD Portrait

Donald Gehlert, PhD

Chief Scientific Officer
Dave Guebert Portrait

Dave Guebert

Chief Financial Officer
Jeanne Bonelle Portrait

Jeanne Bonelle

EVP, Technical Operations
Shahera St. John Portrait

Shahera St. John

VP, Programs
Nico Forte Portrait

Nico Forte

Senior Director, Business Operations and Development
Carole Abel Portrait

Carole Abel

Senior Director Clinical Operations & Program Leader LSD
Madeline Feldman Portrait

Madeline Feldman

Director of Operations & Administration
Collin Gage Portrait

Collin Gage

Vice President of Corporate Development
Rachann McKnight Portrait

Rachann McKnight

Director, Business Process
Jon Polaha Portrait

Jon Polaha

Financial Analyst
Stanley D. Glick, PhD, MD Portrait

Stanley D. Glick, PhD, MD

Scientific Advisor
Natalie Wheeler, PhD Portrait

Natalie Wheeler, PhD

Medical Science Liaison with Dova Pharmaceuticals
Matthew W. Johnson, Ph.D Portrait

Matthew W. Johnson, Ph.D

Clinical Advisor
Kenneth Alper, MD Portrait

Kenneth Alper, MD

Clinical Associate Professor of Psychiatry and Neurology at the New York University School of Medicine
Dr. Peter Gasser Portrait

Dr. Peter Gasser

Clinical Advisor
Sarah McCallum, PhD Portrait

Sarah McCallum, PhD

Associate Professor of Neuroscience and Experimental Therapeutics (DNET) at Albany Medical College
John Rotrosen, MD Portrait

John Rotrosen, MD

Professor of Psychiatry with New York University’s Langone’s Department of Psychiatry
Professor Dr. Matthias Liechti, PhD & M.D. Portrait

Professor Dr. Matthias Liechti, PhD & M.D.

Scientific Collaborator & Advisor
Dr. Kim Kuypers Portrait

Dr. Kim Kuypers

Scientific Collaborator & Advisor
Brigid Makes Portrait

Brigid Makes

Board Director, Chair of Audit Commitee, Member of Compensation, Nomination and Governance Committee
Perry Dellelce Portrait

Perry Dellelce

Chairman, Member of Audit and Compensation, Nomination and Governance Committees
Bruce Linton Portrait

Bruce Linton

Board Director, Chair of Compensation, Nomination and Governance Committee, Member of Audit Committee
Stephen L. Hurst, JD Portrait

Stephen L. Hurst, JD

Co-Founder and Board Director
Scott Freeman, MD Portrait

Scott Freeman, MD

Co-Founder & Clinical Advisor
Leonard Latchman Portrait

Leonard Latchman

Co-Founder